Prescription drugs in the United States are about to get more expensive again. Major pharmaceutical companies say that starting in early 2026 they will increase prices on at least 350 branded medications - despite pressure from President Donald Trump’s administration to make medicines more affordable, DKNews.kz reports.
That’s significantly higher than last year, when companies announced increases on roughly 250 products.
How much will prices rise
On average, price hikes are expected to be around 4%.
According to drugmakers, that:
- roughly matches 2025 levels
- remains below overall inflation
Among the medications affected:
- COVID-19 vaccines
- RSV vaccines
- shingles treatments
- the cancer drug Ibrance
The largest round of increases comes from Pfizer, which will adjust prices on about 80 medicines, mostly by less than 10%.
Why pharma says prices are going up
Companies point to rising costs:
- research and clinical trials are more expensive
- manufacturing and logistics costs are higher
- continued investment in new drugs and vaccines is needed
They insist this is not about “profiting off patients” but about “supporting innovation”.
Still, for people at the pharmacy counter, the bills will be higher.
Politics vs Big Pharma: who wins
The Trump administration argues that drug prices in the US are too high and the system needs reform.
The government is trying to:
- push tougher negotiations with manufacturers
- expand public programs
- increase competition
Yet pharmaceutical giants continue adjusting price lists - gradually and consistently.
What it means for ordinary people
Even a 4% increase can mean:
- higher out-of-pocket costs
- more pressure on insurers
- rising costs across healthcare programs
And for people who rely on lifelong medications - it’s especially painful.
Judging by industry signals, the slow upward trend is likely to continue.
